Citadel Advisors
VRCA icon

Citadel Advisors’s Verrica Pharmaceuticals VRCA Stock Holding History

Citadel Advisors’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,866
Closed -$36.4K – 14510
2025
Q2 		$36.4K Buy
+6,866
New +$36.9K ﹤0.01% 11913
2025
Q1 		– Sell
-2,029
Closed -$14.2K – 15828
2024
Q4 		$14.2K Buy
+2,029
New +$22.3K ﹤0.01% 13412
2024
Q3 		– Sell
-2,278
Closed -$103K – 15506
2024
Q2 		$166K Buy
+2,278
New +$175K ﹤0.01% 10192
2024
Q1 		– Hold
0
– – – 15594
2023
Q4 		– Sell
-1,758
Closed -$72.2K – 15430
2023
Q3 		$68.3K Sell
1,758
-7,075
-80% -$360K ﹤0.01% 11353
2023
Q2 		$510K Buy
8,833
+5,336
+153% +$324K ﹤0.01% 7903
2023
Q1 		$227K Sell
3,497
-3,748
-52% -$227K ﹤0.01% 9952
2022
Q4 		$199K Sell
7,245
-100
-1% -$2.67K ﹤0.01% 10148
2022
Q3 		$215K Buy
7,345
+3,194
+77% +$109K ﹤0.01% 10273
2022
Q2 		$80K Buy
4,151
+1,187
+40% +$59.7K ﹤0.01% 11597
2022
Q1 		$240K Buy
+2,964
New +$244K ﹤0.01% 11107
2021
Q4 		– Hold
0
– – – 14987
2021
Q3 		– Hold
0
– – – 14910

Other funds holding VRCA

CP
Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.27B AUM 18.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return